Molecular characteristics and clinical outcomes of patients with gastroesophageal cancer diagnosed at ages younger than 50 years
JNCI Cancer Spectrum · 09.05.2026 · 10 (3)
DOI: 10.1093/jncics/pkag034 ↗Kurz gefasst
Fachartikel in der Zeitschrift JNCI Cancer Spectrum, online erschienen am 06.04.2026. Verfasst von Michael H Storandt und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Mayo Clinic, Rochester, MN, United States. Hauptthemen laut MEDLINE: Esophageal Neoplasms, Stomach Neoplasms. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
The incidence of gastroesophageal cancer diagnosed at ages younger than 50 years is increasing. Assessment of the clinicopathologic and molecular characteristics of these cancers is limited currently.
Methods
This analysis used Tempus’ clinicogenomic database to compare patients diagnosed with gastroesophageal cancer at ages younger than 50 vs 50 years and older who completed tumor molecular profiling between December 2017 and July 2024. The spectrum of biomarkers, somatic alterations, and germline alterations were compared between those diagnosed with gastroesophageal cancer at ages younger than 50 years and those aged 50 years and older, and a multivariate analysis was conducted to identify factors associated with longer survival.
Results
Among 5863 gastroesophageal cancer patients, 785 had gastroesophageal cancer diagnosed at ages younger than 50 years. There were more females (35% vs 25%, P < .001) and fewer White patients (69% vs 80%, P < .001) with gastroesophageal cancer at ages younger than 50 years. Fewer tumors of patients with gastroesophageal cancer at ages younger than 50 years had high tumor mutational burden (3.2% vs 10.2%, P < .001) or high microsatellite instability (1.7% vs 5.1%, P < .001), but there was no difference in PD-L1 positivity (49% vs 51%, P = .3). Higher incidence of somatic CDH1 mutations was seen in those with gastroesophageal cancer at ages younger than 50 years (16.1% vs 6.6%, q < 0.001) with lower incidence of TP53 (65.6% vs 74.1%), CDKN2A (12.5% vs 19.8%), and KRAS (11.7% vs 18.3%, P < .001 for all) alterations. The most statistically significant germline difference was higher incidence of CDH1 (2.2% vs 0.3%, q = 0.001) and TP53 (0.6% vs 0%, q = 0.039) alterations among those with gastroesophageal cancer at ages younger than 50 years. Median survival for patients with metastatic disease was longer for gastroesophageal cancer at ages younger than 50 years (11 vs 8.5 months, P = .002), and gastroesophageal cancer at ages younger than 50 years, ERBB2 amplification, and high microsatellite instability were associated with superior survival.
Conclusions
Unique molecular and germline profiles were seen in patients with gastroesophageal cancer at ages younger than 50 years, which may suggest differences in causal factors yet undiscovered.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Oncology, Mayo Clinic, Rochester, MN, United States.
- Tempus AI, Inc, Chicago, IL, United States.
- Department of Medicine, Division of Hematology and Medical Oncology, University Hospitals Seidman Cancer Center, Case Western Reserve University, Cleveland, OH, United States.
ORCID-Profile: Michael H Storandt, Emily A Teslow, Yingying Yu, Binyam Yilma, Amit Mahipal, Zhaohui Jin
Zitieren
APA
Storandt, M. H., Teslow, E. A., Yu, Y., Yilma, B., Mahipal, A., & Jin, Z. (2026). Molecular characteristics and clinical outcomes of patients with gastroesophageal cancer diagnosed at ages younger than 50 years. JNCI Cancer Spectrum, 10(3). https://doi.org/10.1093/jncics/pkag034
Vancouver
Storandt MH, Teslow EA, Yu Y, Yilma B, Mahipal A, Jin Z. Molecular characteristics and clinical outcomes of patients with gastroesophageal cancer diagnosed at ages younger than 50 years. JNCI Cancer Spectrum. 2026;10(3). doi:10.1093/jncics/pkag034
BibTeX
@article{Storandt2026,
author = {Storandt, Michael H and Teslow, Emily A and Yu, Yingying and Yilma, Binyam and Mahipal, Amit and Jin, Zhaohui},
title = {Molecular characteristics and clinical outcomes of patients with gastroesophageal cancer diagnosed at ages younger than 50 years},
journal = {JNCI Cancer Spectrum},
year = {2026},
volume = {10},
number = {3},
doi = {10.1093/jncics/pkag034}
}
EUVIMED